| Financial Year |
March 31 2023 |
| Monetary Funds |
1,235,561,907.87 |
| Held-for-trading Financial Assets |
1,834,640.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
5,792,366,542.95 |
| Advances to Suppliers |
1,213,119,536.06 |
| Other Receivables |
117,970,680.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,455,888,082.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
217,965,442.22 |
| Other Current Assets |
135,876,813.43 |
| Total Current Assets |
13,967,022,751.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
268,272,704.80 |
| Long-term Equity Investment |
507,841,650.10 |
| Investment Properties |
205,684,268.86 |
| Fixed Assetes |
2,493,321,296.09 |
| Under-construction Projects |
543,610,117.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
635,500,936.19 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
499,613,981.50 |
| R&D expenses |
-- |
| Goodwill |
410,564,397.25 |
| Long-Term Deferred and Prepaid Expenses |
98,217,238.55 |
| Deferred Income Tax Assets |
138,732,482.17 |
| Other Non-Current Assets |
393,435,934.65 |
| Sub-Total of Non-Current Assets |
6,631,553,162.99 |
| Total Assets |
20,598,575,914.29 |
| Short-Term Loans |
1,635,995,325.50 |
| Trading Financial liabilities |
68,616,388.06 |
| Notes Payable |
-- |
| Accounts Payable |
6,108,557,441.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
125,137,617.20 |
| Taxes Payable |
64,766,668.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
102,814,415.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
829,651,420.41 |
| Other Current Liabilities |
179,080,577.79 |
| Sub-Total of Current Liabilities |
11,270,855,185.01 |
| Long-term Loans |
841,816,869.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
56,450,000.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
17,525,182.03 |
| Deferred Income Tax Liabilities |
22,608,111.46 |
| Other Non-Current Liabilities |
2,034,892,303.05 |
| Sub-Total of Non-Current Liabilities |
3,284,048,836.51 |
| Total Liabilities |
14,554,904,021.52 |
| Paid-In Capital(Or Share Stock) |
6,374,261,088.00 |
| Capital Surplus |
221,102,552.83 |
| Surplus Reserve |
31,118,814.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-605,263,235.56 |
| Minority Stockholder's Interest |
819,003,525.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,224,668,367.44 |
| Owner's Equity（Stockholder's Equity） |
6,043,671,892.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,598,575,914.29 |
